Purine Analogues

Name: Purine Analogues
Accession Number: DBCAT002249
Description: Not Available
ATC Classification: L — ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 — ANTINEOPLASTIC AGENTS
L01B — ANTIMETABOLITES
L01BB — Purine analogues
Drugs: Drug Drug Description
Cladribine A purine antimetabolite used to treat Multiple Sclerosis (MS) and hairy cell leukemia.
Clofarabine A purine nucleoside used to treat relapsed or refractory acute lymphoblastic leukemia in patients 1 to 21 years old.
Fludarabine A purine analog antimetabolite that inhibits DNA synthesis.
Mercaptopurine An antineoplastic agent used to treat acute lymphocytic leukemia.
Nelarabine A purine nucleoside analog and antineoplastic agent used for the treatment of with acute T-cell lymphoblastic leukemia and T-cell lymphoblastic lymphoma with inadequate clinical response to prior chemotherapeutic treatments.
Tioguanine A purine analogue antineoplastic agent used for the induction of remission, and for remission consolidation in patients with acute nonlymphocytic anemias.

Drug	Drug Description
Cladribine	A purine antimetabolite used to treat Multiple Sclerosis (MS) and hairy cell leukemia.
Clofarabine	A purine nucleoside used to treat relapsed or refractory acute lymphoblastic leukemia in patients 1 to 21 years old.
Fludarabine	A purine analog antimetabolite that inhibits DNA synthesis.
Mercaptopurine	An antineoplastic agent used to treat acute lymphocytic leukemia.
Nelarabine	A purine nucleoside analog and antineoplastic agent used for the treatment of with acute T-cell lymphoblastic leukemia and T-cell lymphoblastic lymphoma with inadequate clinical response to prior chemotherapeutic treatments.
Tioguanine	A purine analogue antineoplastic agent used for the induction of remission, and for remission consolidation in patients with acute nonlymphocytic anemias.